American Journal of Preventive Medicine
December 2020 Volume 59Issue 6p773-914
Human Papillomavirus Vaccination Prevalence Among Adults Aged 19–45 Years: An Analysis of the 2017 National Health Interview Survey
Monica L. Kasting, Anna R. Giuliano, Shannon M. Christy, Caroline E. Rouse, Sharon E. Robertson,
Erika L. Thompson
Published online: November 05, 2020
This study estimates the pre-recommendation prevalence of human papillomavirus vaccination and factors associated with vaccination in 2 age groups (19–26 years [young adults] and 27–45 years [mid-adults]), forming a baseline to monitor future coverage among U.S. adults.